SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Rigaud C.)
 

Sökning: WFRF:(Rigaud C.) > Duration of preclin...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00011220naa a2201501 4500
001oai:gup.ub.gu.se/282482
003SwePub
008240528s2019 | |||||||||||000 ||eng|
009oai:DiVA.org:oru-75631
009oai:lup.lub.lu.se:3fdc90f7-a70c-4947-aa85-0c03da727c04
009oai:prod.swepub.kib.ki.se:141409310
024a https://gup.ub.gu.se/publication/2824822 URI
024a https://doi.org/10.1016/j.jalz.2019.04.0012 DOI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-756312 URI
024a https://lup.lub.lu.se/record/3fdc90f7-a70c-4947-aa85-0c03da727c042 URI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1414093102 URI
040 a (SwePub)gud (SwePub)orud (SwePub)lud (SwePub)ki
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Vermunt, L.u Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands4 aut
2451 0a Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
264 c 2019-06
264 1b Wiley,c 2019
500 a Funding Agency:NIA NIH HHS
520 a Introduction: We estimated the age-specific duration of the preclinical, prodromal, and dementia stages of Alzheimer's disease (AD) and the influence of sex, setting, apolipoprotein E (APOE) genotype, and cerebrospinal fluid tau on disease duration. Methods: We performed multistate modeling in a combined sample of 6 cohorts (n = 3268) with death as the end stage and estimated the preclinical, prodromal, and dementia stage duration. Results: The overall AD duration varied between 24 years (age 60) and 15 years (age 80). For individuals presenting with preclinical AD, age 70, the estimated preclinical AD duration was 10 years, prodromal AD 4 years, and dementia 6 years. Male sex, clinical setting, APOE epsilon 4 allele carriership, and abnormal cerebrospinal fluid tau were associated with a shorter duration, and these effects depended on disease stage. Discussion: Estimates of AD disease duration become more accurate if age, sex, setting, APOE, and cerebrospinal fluid tau are taken into account. This will be relevant for clinical practice and trial design. (C) 2019 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Neurovetenskaper0 (SwePub)301052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Neurosciences0 (SwePub)301052 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng
653 a Alzheimer's disease
653 a Disease duration
653 a Preclinical
653 a Prodromal
653 a Dementia
653 a APOE
653 a Clinical setting
653 a Progression
653 a Multistate model
653 a mild cognitive impairment
653 a beta-amyloid 1-42
653 a association workgroups
653 a diagnostic guidelines
653 a national institute
653 a risk-factors
653 a decline
653 a prevalence
653 a neurodegeneration
653 a recommendations
653 a Neurosciences & Neurology
653 a khann g
653 a 1984
653 a neurology
653 a v34
653 a p939
653 a APOE
700a Sikkes, S. A. M.u Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA4 aut
700a van den Hout, A.u Department of Statistical Science, University College London, London, UK4 aut
700a Handels, R.u Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNS), Alzheimer Centrum Limburg, Maastricht University, Maastricht, The Netherlands4 aut
700a Bos, I.u Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNS), Alzheimer Centrum Limburg, Maastricht University, Maastricht, The Netherlands4 aut
700a van der Flier, W. M.u Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands4 aut
700a Kern, Silkeu Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi,Institute of Neuroscience and Physiology,Department of Psychiatry and Neurochemistry, Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden4 aut0 (Swepub:gu)xkersi
700a Ousset, P. J.u CHU Toulouse, Gérontopôle and INSERM UMR 1027, Toulouse, France4 aut
700a Maruff, P.u Cogstate Ltd, Florey Institute, University of Melbourne, Melbourne, Australia4 aut
700a Skoog, Ingmar,d 1954u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi,Institute of Neuroscience and Physiology,Department of Psychiatry and Neurochemistry, Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden4 aut0 (Swepub:gu)xskooi
700a Verhey, F. R. J.u Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNS), Alzheimer Centrum Limburg, Maastricht University, Maastricht, The Netherlands4 aut
700a Freund-Levi, Yvonne,d 1956-u Örebro universitet,Institutionen för medicinska vetenskaper,Department of Neurobiology, Caring Sciences and Society (NVS), Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Old Age Psychiatry, Psychology and Neuroscience, King's College London, London, UK4 aut0 (Swepub:oru)yfi
700a Tsolaki, M.4 aut
700a Wallin, Åsau Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups4 aut0 (Swepub:lu)med-was
700a Rikkert, M. O.u Department of Geriatric Medicine, Radboudumc Alzheimer Centre, Radboud University Medical Center, Nijmegen, The Netherlands4 aut
700a Soininen, H.u Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland4 aut
700a Spiru, L.u "Carol Davila" University of Medicine and Pharmacy, Geriatrics-Gerontology and Old Age Psychiatry Clinical Department -"Elias" University Clinical Hospital, Bucarest, Romenia; "Ana Aslan" International Academy of Aging - The Memory Clinic and Longevity Medicine, Bucarest, Romenia4 aut
700a Zetterberg, Henrik,d 1973u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK; UK Dementia Research Institute at UCL, London, UK4 aut0 (Swepub:gu)xzethe
700a Blennow, Kaj,d 1958u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden4 aut0 (Swepub:gu)xbleka
700a Scheltens, P.u Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands4 aut
700a Muniz-Terrera, G.u Centre for Dementia Prevention, University of Edinburgh, Edinburgh, UK4 aut
700a Visser, P. J.u Karolinska Institutet4 aut
700a Vellas, B.4 aut
700a Reynish, E.4 aut
700a Ousset, P. J.4 aut
700a Andrieu, S.4 aut
700a Burns, A.4 aut
700a Pasquier, F.4 aut
700a Frisoni, G.4 aut
700a Salmon, E.4 aut
700a Michel, J. P.4 aut
700a Zekry, D. S.4 aut
700a Boada, M.4 aut
700a Dartigues, J. F.4 aut
700a Olde-Rikkert, M. G. M.4 aut
700a Rigaud, A. S.4 aut
700a Winblad, B.u Karolinska Institutet4 aut
700a Malick, A.4 aut
700a Sinclair, A.4 aut
700a Frolich, L.4 aut
700a Scheltens, P.4 aut
700a Ribera, C.4 aut
700a Touchon, J.4 aut
700a Robert, P.4 aut
700a Salva, A.4 aut
700a Waldemar, G.4 aut
700a Bullock, R.4 aut
700a Tsolaki, M.4 aut
700a Rodriguez, G.4 aut
700a Spiru, L.4 aut
700a Jones, R. W.4 aut
700a Stiens, G.4 aut
700a Stoppe, G.4 aut
700a Jonhagen, M. E.u Karolinska Institutet4 aut
700a Cherubini, A.4 aut
700a Lage, P. M.4 aut
700a Gomezisla, T.4 aut
700a Camus, V.4 aut
700a Aguera-Morales, E.4 aut
700a Lopez, F.4 aut
700a Savy, S.4 aut
700a Cantet, C.4 aut
700a Coley, N.4 aut
710a Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlandsb Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA4 org
773t Alzheimers & Dementiad : Wileyg 15:7, s. 888-898q 15:7<888-898x 1552-5260x 1552-5279
856u https://cris.maastrichtuniversity.nl/ws/files/71139666/Handels_2019_Duration_of_preclinical_prodromal_and_dementia_stages.pdf
856u http://dx.doi.org/10.1016/j.jalz.2019.04.001y FULLTEXT
8564 8u https://gup.ub.gu.se/publication/282482
8564 8u https://doi.org/10.1016/j.jalz.2019.04.001
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-75631
8564 8u https://lup.lub.lu.se/record/3fdc90f7-a70c-4947-aa85-0c03da727c04
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:141409310

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy